Tranquilli Financial Advisor’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$602K Buy
2,055
+422
+26% +$139K 0.35% 69
2025
Q4
$572K Buy
1,633
+48
+3% +$16.2K 0.33% 69
2025
Q3
$512K Sell
1,585
-183
-10% -$56.9K 0.3% 74
2025
Q2
$688K Buy
1,768
+223
+14% +$89.7K 0.43% 57
2025
Q1
$672K Buy
1,545
+158
+11% +$63.4K 0.43% 54
2024
Q4
$512K Buy
1,387
+171
+14% +$71.6K 0.32% 66
2024
Q3
$632K Sell
1,216
-5
-0.4% -$2.67K 0.4% 58
2024
Q2
$653K Sell
1,221
-8
-0.7% -$4.23K 0.44% 57
2024
Q1
$637K Sell
1,229
-141
-10% -$70.1K 0.43% 57
2023
Q4
$646K Sell
1,370
-108
-7% -$49.9K 0.46% 46
2023
Q3
$644K Buy
1,478
+798
+117% +$362K 0.46% 44
2023
Q2
$302K Buy
680
+125
+23% +$57.7K 0.21% 76
2023
Q1
$255K Buy
555
+41
+8% +$19.5K 0.19% 74
2022
Q4
$264K Buy
+514
New +$261K 0.2% 75

Other funds holding ELV

Tranquilli Financial Advisor's ELV Position: Q1 2026 in Review

Tranquilli Financial Advisor increased its Elevance Health (ELV) stake by 26% in Q1 2026, buying an estimated $139K and bringing the position to 2,055 shares worth $602K. The position accounts for 0.35% of the portfolio, ranked #69.

Tranquilli Financial Advisor first reported a position in ELV in Q4 2022 and has held it in 14 quarters since. The position peaked at $688K in Q2 2025. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Tranquilli Financial Advisor held 2,055 shares of Elevance Health worth $602K as of Q1 2026.
  • Tranquilli Financial Advisor bought 422 Elevance Health shares in Q1 2026, an estimated $139K.
  • Elevance Health made up 0.35% of Tranquilli Financial Advisor's portfolio in Q1 2026, its #69 holding.
  • Tranquilli Financial Advisor first reported a position in Elevance Health in Q4 2022 and has held it in 14 quarters since.
  • Tranquilli Financial Advisor's Elevance Health position peaked at $688K in Q2 2025.
  • 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Tranquilli Financial Advisor's 13F filing for Q1 2026, filed 11 May 2026.